A pharmaceutical line can be washed and still be waiting for permission to work. Excellims builds instruments that bring the chemical answer closer to the production floor.
The Minneapolis life-sciences supplier turned a catalog of repeat-purchase reagents into a $1.2 billion business. Its best lesson is not the pending $11.3 billion exit - it is how one expensive diagnostics detour forced the portfolio back toward tools that scale.